Selective Estrogen Receptor Modulators Differentially Regulate Alzheimer-Like Changes in Female 3xTg-AD Mice
Open Access
- 14 February 2008
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (5), 2607-2611
- https://doi.org/10.1210/en.2007-1346
Abstract
Estrogen-based hormone therapy (HT) in postmenopausal women may reduce the risk of Alzheimer’s disease (AD), although HT remains controversial. One key concern with HT is the potential of adverse outcomes such as breast and uterine cancer. A promising strategy to maximize HT benefits and minimize HT risks is the use of selective estrogen receptor modulators (SERMs) that exert tissue-specific estrogenic effects. To begin investigating the SERM approach in reducing the risk of AD, we investigated whether AD-like neuropathology in the 3xTg-AD mouse model of AD is regulated by the SERMs propylpyrazole triol (PPT) and diarylpropionitrile (DPN) that exhibit relative specificity for estrogen receptor-α and -β, respectively. Consistent with our previous observations, we found that ovariectomy-induced hormone depletion in adult female 3xTg-AD mice significantly increased accumulation of β-amyloid protein (Aβ) and decreased hippocampal-dependent behavioral performance. Treatment with 17β-estradiol (E2) prevented the ovariectomized-induced worsening of both pathologies. PPT treatment was similar to E2 in terms of reducing Aβ accumulation in hippocampus, subiculum, and amygdala but comparatively less effective in frontal cortex. In contrast, DPN did not significantly reduce Aβ accumulation in hippocampus and subiculum, was partially effective in frontal cortex, and nearly as effective as E2 in amygdala. Furthermore, PPT but not DPN mimicked the ability of E2 to improve behavioral performance. These findings provide initial evidence of beneficial actions of SERMs in a mouse model of AD and support continued investigation of SERMs as an alternative to estrogen-based HT in reducing the risk of AD in postmenopausal women.Keywords
This publication has 31 references indexed in Scilit:
- Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD MiceJournal of Neuroscience, 2007
- Neurosteroid estradiol rescues ischemia-induced deficit in the long-term potentiation of rat hippocampal CA1 neuronsNeuropharmacology, 2007
- Selective Estrogen Receptor Modulators for Postmenopausal OsteoporosisDrugs & Aging, 2007
- Selective estrogen receptor modulators and risk for coronary heart diseaseClimacteric, 2007
- Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbensPsychoneuroendocrinology, 2005
- Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formationExperimental Neurology, 2004
- A comparative review of the risks and benefits of hormone replacement therapy regimensAmerican Journal of Obstetrics and Gynecology, 2004
- Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brainExperimental Gerontology, 2000
- Pyrazole Ligands: Structure−Affinity/Activity Relationships and Estrogen Receptor-α-Selective AgonistsJournal of Medicinal Chemistry, 2000
- Comparative distribution of estrogen receptor-? and -? mRNA in the rat central nervous systemJournal of Comparative Neurology, 1997